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  37 
Abstract 38 
Background 39 
Vector-borne apicomplexan parasites are a major cause of mortality and morbidity to 40 
humans and livestock globally. The most important disease syndromes caused by 41 
these parasites are malaria, babesiosis and theileriosis. Strategies for control often 42 
target parasite stages in the mammalian host that cause disease, but this can result in 43 
reservoir infections that promote pathogen transmission and generate economic loss. 44 
Optimal control strategies should protect against clinical disease, block transmission 45 
and be applicable across related genera of parasites. We have used bioinformatics and 46 
transcriptomics to screen for transmission-blocking candidate antigens in the tick-47 
borne apicomplexan parasite, Theileria annulata.  48 
Results 49 
A number of candidate antigen encoding genes were identified which included 50 
domains that are conserved across vector-borne Apicomplexa (Babesia, Plasmodium 51 
and Theileria), including the Pfs48/45 6-cys domain and a novel cysteine-rich domain. 52 
Expression profiling confirmed that selected candidate genes are expressed by life 53 
cycle stages within infected ticks. Additionally, putative B cell epitopes were 54 
identified in the T. annulata genes encoding the 6-cys and cysteine rich domains, in a 55 
gene encoding a putative papain-family cysteine peptidase, with similarity to the 56 
Plasmodium SERA family, and the gene encoding the T. annulata major 57 
merozoite/piroplasm surface antigen, Tams1.  58 
Conclusions 59 
Candidate genes were identified that encode proteins with similarity to known 60 
transmission blocking candidates in related parasites, while one is a novel candidate 61 
conserved across vector-borne apicomplexans and has a potential role in the sexual 62 
phase of the life cycle. The results indicate that a ‘One Health’ approach could be 63 
utilised to develop a transmission-blocking strategy effective against vector-borne 64 
apicomplexan parasites of animals and humans.  65 
Keywords: Theileria annulata, Plasmodium, Babesia, bioinformatic screen, 66 
transmission-blocking vaccine, 6-Cys domain 67 
 68 
Background 69 
Tropical theileriosis is a lymphoproliferative disease of cattle that occurs from 70 
Southern Europe and North Africa in the west, through the Middle East, Central Asia 71 
and Indian sub-continent, to China in the east. The disease is caused by infection of 72 
bovines with the tick-borne apicomplexan parasite Theileria annulata and is a severe 73 
constraint to livestock productivity. Tropical theileriosis can show acute and chronic 74 
forms; with acute disease characterised by fever, weakness and emaciation, swelling 75 
of superficial lymph nodes, destruction of the lymphoid system and pulmonary 76 
oedema. Death from acute theileriosis is common in susceptible Bos taurus cattle and 77 
can occur within 21-28 days. Overt theileriosis has been a major problem in endemic 78 
regions when European cattle have been imported to improve livestock productivity. 79 
However, it is likely that the economic loss from animals undergoing chronic disease 80 
or showing no apparent clinical signs (carriers) is greater than that due to overt 81 
disease. This was demonstrated in a Tunisian study where up to 38 % of overall losses 82 
attributable to tropical theileriosis were associated with reduced milk production by 83 
carrier animals [1, 2]. Thus, to optimise economic output of cattle production in 84 
endemic regions, total control of theileriosis and related tick-borne disease (TBD) is 85 
required. 86 
Current control measures include the use of acaricides, chemotherapy (primarily 87 
buparvaquone) and vaccination. Vaccination, with infected cell lines that develop 88 
attenuated virulence upon long-term culture, has been utilised in several countries [2, 89 
3]. These vaccines can provide protection against clinical disease in the field but do 90 
not prevent establishment of carrier status. Thus, vaccination does not negate 91 
economic loss or the possibility of onward transmission from immunised carrier 92 
animals. In addition, for live vaccines there are potential risks of contamination with 93 
viral pathogens and reversion to virulence, and good quality control and a cold chain 94 
are required for effective delivery. Due to these disadvantages, plus recent reports of 95 
resistance to buparvaquone [4] and problems with continued use of acaricides 96 
(reviewed in [5]) there is a clear need for research into alternative, complementary 97 
control strategies. 98 
An obvious strategy to control tropical theileriosis, and other TBD, is to prevent 99 
onward transmission of the pathogen by the tick vector. The efficacy of targeting ticks 100 
to block disease transmission is well known and has been validated by modelling 101 
studies, risk factor analysis and deployment of acaricides [6-8]. Use of acaricides, 102 
however, has an environmental impact and leads to selection of acaricide-resistant 103 
ticks [9]. The potential for anti-tick subunit vaccines to control tick infestation and 104 
decrease acaricide use has been demonstrated [10], with studies on the hidden gut 105 
antigen of Boophilus microplus (BM86) providing a paradigm model. Vaccination of 106 
cattle using the BM86 orthologue of Hyalomma anatolicum anatolicum (HAA86) 107 
showed that the tick gut antigen partially protected against homologous tick challenge 108 
and also reduced transmission of Theileria annulata [11]. In addition to targeting the 109 
tick, the potential of targeting surface antigens of the Theileria sporozoite and 110 
piroplasm stages to block transmission has been investigated. Antibodies against 111 
SPAG1 can effectively block invasion of the leukocyte by the sporozoite, while a 112 
response against the immunodominant Tams1 antigen has been implicated in blocking 113 
transmission of predominant genotypes [12, 13]. However, both these antigens show a 114 
degree of antigenic diversity in the parasite population that restricts their effectiveness 115 
as vaccine candidates [14-17]. This is particularly pertinent for Tams1 with 116 
identification of many allelic sequences, evidence of domain shuffling to generate 117 
molecular mosaics and the breakthrough of under-represented genotypes encoding 118 
variant Tams1 alleles when a carrier infection is transmitted through ticks [13, 14]. 119 
In order to circumvent antigenic diversity, proteins that perform a function that 120 
requires polypeptide domains to be invariant in the parasite population could be 121 
targeted. A potential advantage of selecting conserved protein domains is that they 122 
may be effective across a range of vector-borne diseases, by targeting processes or 123 
antigens common across related pathogens. One process of vector-borne 124 
Apicomplexans (Babesia, Plasmodium and Theileria) that could involve molecules 125 
conserved across genera is the sexual phase of the life cycle, which is obligatory for 126 
transmission of these parasites through their arthropod hosts. Proteins that function in 127 
the sexual phase and have potential to induce a transmission-blocking response 128 
against Plasmodium spp. have been identified. Surface antigens such as Pfs230, 129 
Pfs48/45, and Pfs25 are known to induce an immune response in vaccinated 130 
mammalian hosts that blocks transmission through the mosquito, thus demonstrating 131 
the feasibility of single or multi-subunit transmission blocking vaccines (TBVs) [18-132 
22]. A considerable number of potential TBV candidates that perform functions 133 
required during the mosquito phase of the Plasmodium life-cycle have since been 134 
characterised (reviewed in [23]). 135 
In the present study, a screen for parasite antigens with the potential to induce a 136 
transmission-blocking response against T. annulata was conducted. A combination of 137 
bioinformatic prediction and transcriptional expression profiling was used to obtain a 138 
panel of candidates, a number of which have homologues across genera of related 139 
vector-borne Apicomplexa. Analysis of the expression levels of four candidate genes 140 
in the tick vector, together with investigation of their predicted antigen diversity (in 141 
silico) provides evidence that development of transmission-blocking strategies which 142 
can operate across related vector-borne Apicomplexa may be possible. 143 
  144 
Methods 145 
Bioinformatic screening 146 
A bioinformatic approach was used to identify Theileria annulata genes encoding 147 
proteins predicted to be located on the parasite surface using information representing 148 
3772 genes contained in the genomic databases, GeneDB 149 
(http://www.genedb.org/Homepage/Tannulata) and EuPathDB (http://eupathdb.org). 150 
Genomic annotation data was downloaded using the ‘List Download’ feature of 151 
GeneDB. Candidate genes encoding putative surface antigens were selected on the 152 
basis of motifs predicted to be present on the encoded protein, namely a signal peptide, 153 
a GPI-anchor signal and/or one or more transmembrane domains. Database prediction 154 
for signal peptide (SignalP 2.0 HMM), GPI-anchor signal (DGPI v2.04) and 155 
transmembrane domains (TMHMM Server v2.0) were utilised using default settings. 156 
For TA20855 and related homologues, sequences were also analysed using the 157 
SignalP 3.0 Server (http://www.cbs.dtu.dk/services/SignalP-3.0/) and SignalP 4.1 158 
Server (http://www.cbs.dtu.dk/services/SignalP-4.1/). Integral membrane proteins 159 
with multiple predicted transmembrane domains were excluded. A subset of Theileria 160 
annulata genes that display elevated levels of mRNA expression from the 161 
macroschizont to the piroplasm stage of the life cycle in the vertebrate host were 162 
identified using a published microarray dataset [24, 25]. Hierarchical clustering of 163 
log2-transformed gene expression levels and profiles of gene expression values across 164 
stages (sporozoite to piroplasm) were performed using DNASTAR Array Star3 165 
software, as described [25]. The NCBI database was BLAST searched 166 
(https://blast.ncbi.nlm.nih.gov/) to identify homologues of candidate genes in other 167 
vector-borne Apicomplexan parasites, namely Plasmodium spp., Theileria spp. and 168 
Babesia spp. 169 
Revised annotation of TA20855 and TA19820 170 
Following alignment of homologs across genera for T. annulata genes TA20855 and 171 
TA19820 it was observed that conservation of amino acid sequence observed for other 172 
apicomplexa was not obtained with sequence predicted for the T. annulata genes. 173 
Analysis of the gene DB entry sequence, however, showed both genes contained 174 
multiple introns and sequence with greater identity to the predicted amino acid 175 
sequence conserved across genera. An altered open reading frame was then identified 176 
and used to generate a revised amino acid sequence with greater conservation across 177 
genera. In order to verify that the revised predicted amino acid sequences were 178 
accurate, we used available next generation sequencing data. RNA-seq reads 179 
generated from sheep B-cells inoculated with T annulata stabilate (Ta Ankara, 180 
stabilate 89) for another experiment were kindly provided by Prof Ivan Morrison 181 
(Roslin Institute, University of Edinburgh). These RNA reads were of sufficient depth 182 
to provide coverage across the predicted TA20855 and TA19820 genes. Using the 183 
Bowtie 2 sequence aligner [24] RNA-seq reads were aligned to the predicted CDS of 184 
TA20855 and TA19820 provided on GeneDB. As expected, analysis of the created 185 
contigs revealed significant gaps in coverage, suggesting incorrect annotation and the 186 
presence or absence of introns.  187 
The revised predicted amino acid sequences (designed to maximise orthology across 188 
Apicomplexa) were then aligned with the gDNA sequences (using Genewise Protein-189 
nucleotide alignment software) to generate a new gene model and predicted CDS for 190 
both genes. The RNA seq reads were then mapped to the new predicted CDS 191 
sequences using Bowtie 2. The revised contigs showed much greater overlap between 192 
reads and coverage, including regions where incorrectly annotated introns and exons 193 
were responsible for the frame shifts in the original GeneDB gene models. Further 194 
revision to the predicted CDS was made to close gaps in RNA-seq coverage caused 195 
by other unidentified intron or exons, resulting in complete coverage and overlapping 196 
mRNA reads across the CDS (see Figures A and D in Additional file1). For TA20855, 197 
the final gene model results in 11 exons in contrast to 8 in the GeneDB model, while 198 
for TA19820 the revised gene model results in the lengthening of 3 introns, and the 199 
inclusion of one more intron in contrast to the GeneDB entry (see Figures B and E in 200 
Additional file 1). The revised mRNA sequence for both genes is extremely similar to 201 
the reference genome sequence, with only a handful of SNPs.  202 
 203 
qRT-PCR on selected candidate genes for a time course of T. annulata infected ticks  204 
4100 ticks (Hyalomma anatolicum anatolicum) were fed on a calf infected with 205 
T. annulata Ankara sporozoite stabilate A10/BT (applied to the calves on Day 8 to 206 
Day 12 post-infection) with the parasitaemia peaking at 4 % on Day 14. Engorged 207 
ticks were collected (stored at 15 °C, until collection of all ticks post-detachment) and 208 
then incubated at 28 °C for 2, 6, 10 and 15 days, followed by freezing in RNAlater® 209 
(Thermo Fisher Scientific) at -80 °C. These time-points represent early events in 210 
gametocyte maturation (Day 2) together with gamete (Day 6 -10), zygote (Day 10) 211 
and kinete (Day 15) production, as reported previously [25, 26]. 400 frozen ticks for 212 
each time-point were crushed in liquid nitrogen and RNA extracted using TRIzol 213 
Reagent (Invitrogen) following the manufacturer’s protocol. Four candidate genes 214 
(TA10955, TA17050, TA03640 and TA20855) were selected for qRT-PCR based on 215 
bioinformatically predicted characteristics, microarray gene expression profile and 216 
detection of orthologues in other vector-borne Apicomplexa. Primers were designed 217 
(Additional file 2) and qRT-PCR was performed as described previously [27]. Briefly, 218 
500 ng of total RNA from each sample was used to synthesise cDNA using the 219 
Affinity Script cDNA Synthesis Kit (Agilent Technologies) and Oligo-dT as primer. 220 
1 μl cDNA for each sample was used for qRT-PCR, using the Brilliant III Ultra-fast 221 
SYBR®Green qPCR Master mix (Agilent technologies) and the Stratagene Mx3005P 222 
system. Comparative quantitative analysis of gene expression across time-points was 223 
performed using Stratagene MxPro Software, with RNA from a merozoite Day 8 224 
culture used as the calibrator. HSP70 (TA11610) and HSP90 genes (TA10720) were 225 
utilised as controls for constitutive expression, based on their transcriptional profile 226 
through the life-cycle [27]. Differences in mean fold-change between time-points in 227 
candidate gene expression level were tested using Student’s t-test; P-values obtained 228 
are denoted in the Results section and in Figure Legends. 229 
Allelic dN/dS and epitope mapping for selected candidate genes 230 
Analysis of allelic sequences generated from DNA samples from different T. annulata 231 
isolates from four different geographic origins was performed, with ratios of dN/dS 232 
computed to screen for evidence of diversifying positive selection for amino acid 233 
substitution on a codon-by-codon basis. The DNA samples were: T. annulata Ankara 234 
(Turkey), Hissar (India), 9A (Tunisia) and UmBanein24 (Sudan). PCR for genes of 235 
interest was performed on DNA from each of the four isolates and the resulting PCR 236 
amplicons were cloned and sequenced. Primers were specifically designed to amplify 237 
almost the entire length of Tams1 (TA17050), putative papain-family cysteine 238 
protease (TA10955), and hypothetical protein TA20855 (Additional file 2). TA03640 239 
was too large for the whole gene to be sequenced (>3000 bp), so for preliminary 240 
analysis two shorter fragments (~1500 bp and 2000 bp) were amplified, and five test 241 
sequences for each fragment generated. As this showed the second segment of the 242 
gene to be more polymorphic than the first, this region was chosen for further 243 
investigation of allelic polymorphism. Optimum annealing temperatures for each 244 
primer pair were determined (Additional file 6) and, to minimise the chance of PCR 245 
error in amplicons, Pfu Turbo DNA polymerase (Agilent Technologies) or KAPA 246 
HiFi (Kapa Biosystems,) polymerase was used in the PCR reaction, according to the 247 
manufacturer’s guidelines. PCR products were cloned into pCR®4Blunt-Topo vector 248 
(Invitrogen) and used to transform competent E. coli, using standard methodology. 249 
For TA17050 and TA10955, twelve colonies from each isolate were selected and 250 
inserts sequenced in both directions (96 total sequences for each gene) by Genoscreen 251 
(Lille, France). For TA20855 and TA03640, six colonies from each isolate were 252 
selected and sequenced in both directions (48 total sequences for each gene) by 253 
Eurofins (Berlin, Germany). The assembled sequences were translated and aligned to 254 
the GeneDB reference amino acid sequences (GenBank accession n° XP_953719, 255 
XP_953243, XP_954368) using CLC Genomics Workbench software and 256 
polymorphic sites identified. The datasets of allelic sequences were then used to 257 
estimate the ratio of non-synonymous to synonymous base-pair substitutions  (dN/dS) 258 
for each codon in each gene and for the entirety of the selected gene or region using 259 
the SLAC algorithm of the online Datamonkey program (http://www.datamonkey.org 260 
[28]). The SLAC method is a conservative method for calculation of dN/dS that 261 
prevents overestimation of positive selection [29]. Finally, we used the Bepipred 262 
linear B-cell epitope prediction tool 263 
(http://tools.immuneepitope.org/tools/bcell/iedb_input) [30] to predict areas of each 264 
gene that could form B-cell epitopes. Data from both types of analysis were then 265 
overlaid to visualise any regions for each candidate gene where evidence for selection 266 
of amino acid substitution and prediction of a B cell epitope overlapped. 267 
  268 
Results 269 
Bioinformatic and transcriptomic profile analysis identifies T. annulata 270 
transmission-blocking candidate genes 271 
To screen for T. annulata candidate genes encoding proteins that may be expressed by 272 
life cycle stages present in the tick vector a combined genomic and transcriptomic 273 
approach was taken. A screen of available genomic data was used to identify genes 274 
encoding proteins with a predicted signal peptide domain together with a GPI anchor 275 
domain, resulting in a list of 44 genes. Seven genes did not have direct orthologues in 276 
the closely related Theileria parva and were removed from the list. A further seven 277 
genes encoding proteins with multiple transmembrane domains were also removed, as 278 
likely to be integral membrane proteins, and so potentially less suitable as 279 
transmission blocking candidate antigens, leaving 30 candidate surface protein 280 
encoding genes.  Microarray-derived transcriptomic data across all bovine life-cycle 281 
stages together with the tick-derived sporozoite stage was then analysed for these 282 
candidate genes [27]. From this, a subset of genes was selected which displayed an 283 
expression pattern that indicated rising mRNA levels from macroschizont through to 284 
piroplasm, the stage that is taken-up by the tick vector. Genes were selected on the 285 
basis of an absolute fold-change of greater than 2 between the macroschizont and 286 
merozoite and/or piroplasm stages. This resulted in a subset of 13 candidate genes 287 
(Table 1). 288 
Expression profiles were constructed across all stages, for which data was available, 289 
with candidate genes grouped into three profile types (see Figure 1). In the first 290 
profile (A): genes TA13810, TA17050 and TA20855 showed elevation of expression 291 
from macroschizont through to the merozoite/piroplasm and the level of expression in 292 
the sporozoite was similar to that of the macroschizont (<2 fold difference). In the 293 
second profile (B): genes TA02580, TA03640, TA03755, TA16565, TA17220, showed 294 
elevation of expression through to the merozoite/piroplasm stages and had a 295 
significantly higher level of expression (>2 fold) in the sporozoite relative to the 296 
macroschizont stage, and the expression level in the sporozoite was higher than that 297 
for the merozoite/piroplasm. In the third profile (C): genes TA02585, TA16005, 298 
TA10955 and TA13825 showed expression levels that were higher in sporozoite than 299 
in macroschizont and either comparable between sporozoite and piroplasm or lower in 300 
the sporozoite. Within these profiles two genes previously considered as transmission-301 
blocking candidates were identified. Tams1 (TA17050) showed expression consistent 302 
with profile A, while SPAG1 (TA03755) showed expression consistent with profile B. 303 
It was concluded that these profiles indicate the potential for the gene to be expressed, 304 
either transiently in the tick following a blood meal, or at an elevated level that is 305 
coincident with the development of stages within the tick vector. 306 
Identification of candidate genes showing domain conservation across vector-307 
borne Apicomplexa 308 
To determine if any of the candidate genes are predicted to possess domains that 309 
perform a conserved function, their entries in GeneDB were examined and BLAST 310 
analysis for homologues in other Apicomplexa was carried out. Tams1 (TA17050) 311 
and SPAG1 (TA03755) have been characterised extensively with orthologues 312 
identified across the Theileria genus, they have no known domains that show 313 
conservation across the vector-borne Apicomplexa. 314 
TA02580 and TA02585 encode putative surface proteins of unknown function with 315 
respective orthologues only identified in T. parva. TA13810 was identified as the 316 
direct orthologue of the gene encoding the ts-chitose type 23 kDa piroplasm surface 317 
protein of T. sergenti [31] and is conserved across bovine Theileria spp.; an 318 
orthologue was not identified for other vector-borne Apicomplexa. Similarly, 319 
orthologues of TA13825 were only identified in Theileria ssp. (T. parva, 320 
T. orientalis/buffeli and T. equi) and showed similarity to the 23 kDa piroplasm 321 
surface protein. TA16005 encodes a protein of unknown function that is also restricted 322 
to Theileria species. TA17220 has a probable orthologue in T. parva and shows 323 
similarity to an uncharacterised predicted protein in T. orientalis. TA16565 is 324 
annotated as an uncharacterised surface protein with orthologues in both Theileria and 325 
Babesia genera (E-value-1.5E-17, B. bovis; - 9.5E-19, B. bigemina; 3.2E-25, B 326 
microti).  327 
 TA10955 is annotated in GeneDB as encoding a putative papain-family (clan CA) 328 
cysteine protease (Pfam: PF00112, E-value=1.86E-12) with a signal peptide and GPI 329 
anchor. BLAST analysis identified similarity (30 % identity, 49 % similarity) to the 330 
Serine repeat antigen 5 of Plasmodium falciparum that covers the predicted peptidase 331 
domain (218 - 476) of TA10955. Conservation of the domain (see Figure 2A) was 332 
found in predicted proteins of related Theileria species (T. orientalis and T. parva) as 333 
previously reported [32], but not in Babesia or T. equi. 334 
Gene TA03640 is annotated as encoding a hypothetical protein with a signal peptide 335 
and GPI anchor. It is also annotated as encoding an s48_45 domain between aa 1020-336 
1135 (Pfam: 07422, E-value-1.2E-17) found in the 6-cys family of Plasmodium 337 
surface proteins (e.g. Pfs 48/45 and Pfs 230) that play an important role in gamete 338 
fertilisation in Plasmodium [33, 34]. The domain contains 6 conserved cysteines that 339 
form 3 disulphide bridges necessary for correct protein folding. The s48/45 domain is 340 
conserved across the vector-borne Apicomplexa with orthologues present in Theileria 341 
and Babesia species, as well as Plasmodium. The alignment represented in Figure 2B 342 
shows strong positional conservation of the 6 cysteines of the Theileria domain with 343 
orthologues in Plasmodium and Babesia. 344 
TA20855 is annotated in Gene DB as encoding a hypothetical surface protein of 297 345 
aa with similarity to Plasmodium hypothetical proteins. Clear homologues with 346 
significant similarity (>50 %) were identified by BLAST across the Apicomplexa 347 
(Babesia, Plasmodium, Toxoplasma, Hammondia), with the highest level of similarity 348 
spanning a region containing conserved cysteine residues. However, based on identity 349 
of predicted amino acid sequences across other genera, compared to that identified for 350 
the Theileria orthologues, it was concluded that the original annotation of intron exon 351 
junctions in TA20855 on GeneDB predicted an incorrect open reading frame, with the 352 
TA20855 sequence diverging from those of related genera at aa 255. A revised gene 353 
model (based on homology of predicted aa sequence across genera) encoding a 354 
protein of 289 aa was then validated using available RNA seq data, with complete 355 
coverage of the revised polypeptide coding sequence obtained (see Additional file 1). 356 
Using the revised gene model, homology over a region spanning aa 128 – 282 (58 % 357 
similarity; minimum E-value 2E-18) was found across genera of Apicomplexa, and 358 
Vitrella brassicaformis, a chromerid that evolved from a common ancestor shared 359 
with the Apicomplexa [35]. This region of homology contains 8 positional conserved 360 
cysteine residues and spans at least one predicted transmembrane (TM) helix, with a 361 
second more C-terminal helix predicted in some instances (depending on the sequence 362 
modelled or the algorithm used; see Figure 2C and Additional file 1. Both these 363 
predictions, plus the prediction of a cleaved signal peptide (T. annulata; B. bovis, B. 364 
bigemina, Vitrella brassica (using both SignalP 3.0 and 4.1) and T. gondii (SignalP 365 
3.0 but not 4.1)), indicate that the majority of the encoded polypeptide (a helical rich 366 
region) is to the extracellular side of the membrane. For Plasmodium polypeptides, 367 
while a cleaved signal peptide is predicted by SignalP 3.0, an alternative model with 368 
the helical rich region on the cytoplasmic face is also indicated, as a transmembrane 369 
helix is also denoted within the putative signal peptide region in their EuPathDB 370 
entries. Thus, gene TA20855 is likely to encode a membrane protein that is conserved 371 
across related vector borne genera and was present in a common ancestor of the 372 
apicomplexans and chromerids. 373 
Elevated expression of candidate genes in tick stages of T. annulata  374 
To assess potential expression of selected candidate genes in tick stages of 375 
T. annulata, qRT-PCR was performed on RNA representing a developmental time-376 
course after engorgement of ticks on a piroplasm-infected animal. Four genes were 377 
selected representing the A (TA17050 and TA20855), B (TA03640) and C (TA10955) 378 
microarray expression profiles. These genes include a Theileria-specific candidate 379 
(TA17050), a candidate that showed homology with Plasmodium proteins (TA10955) 380 
and two candidates (TA03640 and TA20855) with homologues present in vector-borne 381 
Apicomplexa.  382 
As illustrated in Figure 3A, the expression profile for TA17050 (Tams1) showed a 383 
drop in expression at day 2, relative to the merozoite stage calibrator RNA (2.1-fold, 384 
absolute), which continued as the infected tick time-course progressed to Day 15 (39-385 
fold reduction). TA10955 (the putative papain-family cysteine protease gene) showed 386 
a decrease (>3-fold, absolute) in expression at Day 2 post-detachment of ticks relative 387 
to merozoite RNA (see Figure 3B). However, in contrast to Tams1, from day 2 388 
onwards, expression of TA10955 increased as the tick time-course progressed, with a 389 
marked significant (p < 0.001) elevation at Day 15 (> 7000 fold absolute at Day 15, 390 
relative to merozoite RNA). 391 
For TA03640, significant elevated expression was not detected at the early time-points. 392 
By Day 10, however, expression levels were increased significantly relative to 393 
merozoite and Day 2 (>13 fold absolute, p < 0.0001), and this was sustained at Day 394 
15 (Figure 3 C). A related expression profile was obtained for TA20855 with 395 
expression significantly elevated at Day 6, relative to Day 2 (p = 0.002), and a further 396 
increase (>3-fold absolute, p < 0.001) at Day 10 relative to Day 6 (Figure 3D). 397 
However, unlike TA03640, a significant fall (p < 0.001) in expression between Day 398 
10 and Day 15 occurred (>10-fold, absolute decrease) to a level below that of the Day 399 
6 time-point (>3-fold, absolute decrease). To compare expression profiles for the 400 
Plasmodium and Toxoplasma homologues of TA20855, data available in EuPathDB 401 
was mined. This demonstrated that for all Plasmodium homologues for which data is 402 
available, RNA is up-regulated in late stage (V) gametocytes, indicating a putative 403 
role in transmission via the mosquito vector (Additional file 2), while in Toxoplasma 404 
the highest level of expression was associated with unsporulated oocysts. 405 
Assessment of dN/dS and in silico prediction of B cell epitopes of transmission-406 
blocking candidate genes 407 
Genes encoding antigens exposed to a protective immune response often display an 408 
elevated ratio of non-synonymous (dN) nucleotide substitution to synonymous 409 
substitution (dS) across allelic sequences [36, 37]. In contrast, genes encoding 410 
proteins specific to vector stages and not exposed to an acquired protective immune 411 
response may show more limited levels of selection for amino acid substitution [38]. 412 
To assess whether the putative proteins encoded by transmission-blocking candidate 413 
genes may be exposed to the immune response or act as hidden antigens, the level of 414 
dN/dS was computed for three candidate genes with evidence of elevated expression 415 
in tick stages. This was performed in comparison to the Tams1 gene, as the level of 416 
dN/dS has been found to be relatively high among Tams1 alleles [14, 16]. Allelic 417 
sequences were generated for all four selected genes from DNA representing a panel 418 
of parasite isolates: T. annulata Ankara (Turkey), Hissar (India), 9A (Tunisia) and 419 
UmBanein24 (Sudan). For each gene a minimum of 48 sequences were obtained and 420 
distinct consensus sequences selected. The dN/dS ratio was then computed as: 0.48 421 
for Tams1 (TA17050) with six significantly positive selection sites at p < 0.1; 0.13 for 422 
TA10955 with three significantly positive selection sites at p < 0.1; 0.19 for TA03640 423 
with no positively selected sites at p < 0.1; and 0.31 for TA20855 with no significantly 424 
positively selected sites at p < 0.1. Thus, as expected, Tams1 (TA17050) was shown to 425 
be the gene with strongest evidence for selection of amino acid substitutions. In 426 
contrast, the overall dN/dS ratio of TA10955, TA03640 and TA20855 was lower and 427 
few (TA10955) or no statistically significant positively selected sites were identified. 428 
However, visualisation of dN/dS plots (Figure 4) revealed a degree of clustering of 429 
codons where dN/dS values were positive; this indicated that non-synonymous amino 430 
acid substitutions were tolerated, although there was insufficient power to determine 431 
these as statistically significant. 432 
Amino acid substitutions that are positively selected to allow evasion from immune 433 
detection could be expected to coincide with the position of antigenic epitopes of 434 
Theileria proteins, as demonstrated for the T cell antigen gene, TA9 [37]. We used B-435 
cell antibody epitope prediction software to identify regions of each protein where 436 
putative antibody epitopes could be detected. Using the Bepipred linear epitope 437 
prediction algorithm, individual amino acid residues were denoted as being within or 438 
outside predicted B-cell epitopes and this data superimposed onto the dN/dS plots. 439 
Preliminary inspection suggested that for at least some of the candidate genes, overlap 440 
exists between regions harbouring amino acid substitutions and predicted B cell 441 
epitopes (see Figure 4). To test overlaps for statistical significance, every residue was 442 
classified for predicted epitope (yes or no) and evidence of positive selection (i.e. 443 
positive dN/dS values: yes or no) and a chi-square test performed. For candidate 444 
genes (TA10955 and TA20855) there was a robust relationship between regions of 445 
amino acid substitution and regions of predicted epitopes: thus, sites with positive 446 
dN/dS scores, though rare, were significantly more likely to occur in regions of 447 
predicted epitopes than in non-epitope regions (TA10955 X2 = 6.53 p = 0.011; 448 
TA20855 n = 243 X2 = 938 p = 0.002). Taken together, the results suggest that these 449 
two candidate genes encode polypeptides with putative B-cell epitopes that exhibit 450 
weak, but detectable, evidence for selection of amino acid substitution. 451 
  452 
Discussion 453 
The primary aim of this study was to use a bioinformatic approach to identify 454 
candidate genes encoding proteins with the potential to induce an immune response 455 
that could block transmission of Theileria annulata by the tick vector. Moreover, 456 
given that sexual reproduction is likely to have been retained by all vector-borne 457 
Apicomplexa [39], a secondary aim was to identify candidate genes that show a 458 
degree of conservation across Theileria species and related genera, particularly 459 
Babesia, as the two genera can be endemic over the same geographical region [40]. 460 
Two types of transmission-blocking candidate antigen were predicted: firstly (type 1), 461 
surface antigens required for the early phase of infection in the tick may be expected 462 
to be present in the bovine host and exposed to its acquired immune response, hence 463 
these antigens were expected to display a degree of antigenic diversity; secondly (type 464 
2), surface proteins exclusive to stages present within the tick that perform an 465 
important biological function, such as gamete fertilisation, and may possess conserved 466 
epitopes that could induce a transmission-blocking antibody response if used as an 467 
antigen. 468 
Based on results of our screen we identified twelve candidate genes, some of which 469 
possessed characteristics that allow placement into either type 1 or type 2 antigens. 470 
Thus, genes whose microarray expression level is elevated in the piroplasm but lower 471 
in the sporozoite stage are more likely to be expressed as proteins at the 472 
merozoite/piroplasm stage and may be present only in the initial phase of infection in 473 
the tick vector. This premise is supported by the observation that this group includes 474 
the genes, TA17050 and TA13810, which encode the known major 475 
merozoite/piroplasm surface antigen, Tams1, and the 23 kDa piroplasm surface 476 
antigen. Expression in the tick was determined for Tams1 where the RNA level was 477 
shown to fall within 2 days (at 28 °C post-detachment) and continued to fall over the 478 
remainder of the tick time-course. Thus, it can be predicted that synthesis of Tams1 479 
protein (and by extrapolation possibly the 23 kDa piroplasm surface antigen) is 480 
significantly reduced (or absent) following generation of gamete forms (Day 6 - 10). 481 
This does not preclude a role for Tams1 as a transmission-blocking candidate, as 482 
piroplasms may persist for days within the tick; the protein may be stable and the 483 
antigen has been detected in infected tick protein extracts (Mohamed Dargouth, 484 
personal communication). 485 
The results for TA20855 show that it would be unwise to predict an expression profile 486 
for tick stages based solely on the available microarray data. TA20855 shows a 487 
similar microarray profile to that of Tams1 (TA17050) but we have shown by qRT-488 
PCR analysis that peak expression of TA20855 does not occur until around Day 10 489 
post-detachment, a time-point associated with gamete fertilisation and production of 490 
zygotes [25]. The rapid fall in expression at the Day 15 time-point suggests a transient 491 
role prior to the production of kinetes, with a logical prediction being that the encoded 492 
protein is specific to gametes and perhaps performs a role in fertilisation or zygote 493 
development, although a role post Day 10 cannot be totally discounted if the protein is 494 
highly stable. BLAST analysis revealed a region of considerable identity, particularly 495 
over a predicted 8-cysteine structural domain, with genes encoding predicted 496 
membrane proteins in other Apicomplexa and in the chromerid, Vitrella. Homologues 497 
in Plasmodium show a transient peak in late-stage gametocytes (Additional file 3), 498 
while differential expression in Toxoplasma shows elevated expression associated 499 
with the unsporulated oocyst. The results suggest that this gene could be a remnant of 500 
the ancestral machinery of apicomplexan sexual reproduction. Based on the gene 501 
model it is likely to be an integral membrane protein, but with a significant proportion 502 
predicted to be extracellular. The region of greatest amino acid identity across 503 
homologues contains 8 spatially conserved cysteines and spans the region(s) predicted 504 
to act as a transmembrane helix. TM helices with conserved patterns of residues are 505 
unusual and indicate potential functional significance [41]. This is supported by 506 
evidence for conservation of amino acid substitution across T. annulata alleles in the 507 
region of the molecule predicted to be within the cell membrane or cytoplasm (see Fig 508 
4D). The function on the molecule can only be speculated upon at present, but the two 509 
most likely possibilities are as a ligand or a structural surface molecule that protects 510 
the parasite from the extracellular environment. 511 
Genes that display an elevated level of RNA expression associated with the sporozoite 512 
stage may encode surface proteins whose function is primarily required after gamete 513 
fertilisation/zygote production. The gene (TA03755) encoding the major sporozoite 514 
surface antigen SPAG-1 [42] and a gene encoding a putative papain cysteine protease 515 
were placed in this category. TA10955 was found to display peak expression at Day 516 
15 of the tick time-course, indicating that the encoded protein may not be present until 517 
the later part of the life cycle in the tick. The predicted protein shows strongest 518 
similarity to the serine repeat antigen family (SERA) of P. falciparum, identified as 519 
important asexual blood-stage antigens (reviewed by [43]).  The Theileria SERA 520 
represents a phylogenetic out-group to Plasmodium SERAs [32], with similarity over 521 
the peptidase domain of the predicted protein, but not the antigenic N-terminal 522 
domain identified for Plasmodium SERA5. Members of the Plasmodium SERA 523 
family function in merozoite egress, and have been implicated in sporozoite egress 524 
from the oocyst within the mosquito, providing a potential target for transmission 525 
blocking strategies [32, 44]. Based on its RNA expression pattern, the Theileria 526 
protein may function in a similar manner, promoting release of kinetes or sporozoites 527 
from infected tick cells. Whether this involves a surface associated location or 528 
secretion of the proteinase into the host cell environment would require validation. 529 
The TA03640 gene has an expression profile that is similar to TA20855 but does not 530 
show a significant drop at Day 15. It is expressed at a higher level in the sporozoite 531 
relative to the merozoite/piroplasm, suggesting that production of the protein occurs 532 
within the tick.  TA03640 contains a pfs48_45 domain present in members of the 6-533 
cys family in Plasmodium, including the gametocyte and gamete surface proteins 534 
Pfs48/45 and Pfs230 [33, 34]. Expression of a 6-cys encoding gene in B. bovis has 535 
been reported in merozoites [45]. However, a more recent study demonstrated low 536 
level expression in blood stages and elevated expression of at least seven out of ten B. 537 
bovis 6-cys genes by stages within the tick vector [46]. Thus, the elevated expression 538 
at the Day 10 and 15 time-points post-tick detachment suggests that Theileria 539 
TA03460 may play a role in mediating transmission, as proposed for related vector-540 
borne Apicomplexa. Based on demonstration that antibody responses generated 541 
against Plasmodium P48/45 and P230 can block transmission [34,[47] 6-cys domain 542 
surface antigens provide a target for development of transmission blocking vaccines 543 
against Theileria as well as Babesia [48].  544 
The in silico analysis performed in this study indicated that the tested genes encode 545 
predicted B cell epitopes indicating that they have antigenic properties. In general, 546 
and relative to the merozoite/piroplasm major antigen gene Tams1, amino acid 547 
diversity is limited and no positively selected amino acid substitution sites were 548 
predicted for TA03640 or TA20855. This could be taken as evidence that they may 549 
operate as “hidden antigens” and provide a target that shows conservation across 550 
species isolates, as proposed for the Babesia 6-cys candidate genes [48]. However, for 551 
TA20855 (and TA10955) predicted epitopes coincided with certain positions where 552 
there is evidence for allelic amino acid substitution, and these were most evident in 553 
the region of the molecule modelled to be on the extracellular side of the cell 554 
membrane (i.e. N-terminal of residue 217). Evidence for selection of amino acid 555 
substitution has been reported for transmission-blocking proteins in Plasmodium, with 556 
the conclusion that this is driven by a protective immune response and/or mating 557 
interactions [34]. The former would require exposure to an acquired immune response, 558 
which has been shown to occur for Plasmodium transmission blocking antigens ([34] 559 
and references therein). Although our data indicates mRNA expression peaks in 560 
stages found within the tick, further work is required to assess whether polypeptides 561 
encoded by TA10955, TA03640 and TA20855 are hidden from or exposed to the 562 
immune response of the bovine host.  563 
Tams1 (TA17050) alleles showed the highest dN/dS ratio with six significant positive 564 
selection sites: however, areas of amino acid substitution did not show strong co-565 
localisation with predicted B cell epitopes. One possible explanation is that divergent 566 
epitopes for this surface antigen are thought to be highly conformational dependent, 567 
are sensitive to mild periodate treatment and may not have been predicted by the 568 
algorithm. In addition, epitopes that are internal to the folded molecule and are not 569 
exposed to a protective immune response are likely [48]. Thus, to be fully effective as 570 
a vaccine candidate an antigen profile encompassing a wide range of divergent 571 
epitopes would need to be generated.   572 
Based on the results of this study, at least two genes (TA03640, TA20855) 573 
demonstrate that transmission-blocking candidates can show a degree of conservation 574 
across related genera (Babesia, Theileria, Plasmodium). This implies that additional 575 
candidates may exist, as several other classes of protein are known to play a 576 
functional role in transmission of Plasmodium. Indeed, a preliminary screen for 577 
Theileria orthologues of Plasmodium transmission-blocking candidate genes and 578 
analysis (using criteria defined in methods) of the expression profile in T. annulata 579 
yields several other candidates (see Additional files 4, 5 and 6) including: a second 580 
Theileria 6-cys gene (TA14250); a gene (TA09115) with orthology to genes encoding 581 
the HAP2 protein that has been proposed to function as a gamete membrane fusogen 582 
in Plasmodium and many other protists [49-51]; a gene (TA19820) encoding a domain 583 
with orthology to the CPW-WPC domain encoded by surface proteins associated with 584 
Plasmodium transmission stages including the developing ookinete [52]. Further 585 
candidates are likely to be identified with a genome wide screen comparing bovine to 586 
tick stage transcriptome data. 587 
Conclusions  588 
A bioinformatics screen has identified candidate genes encoding proteins with 589 
characteristics that allow prediction they have potential to block transmission of 590 
Theileria parasites. Given the economic loss associated with sub-clinical infection of 591 
T. annulata and the role of carrier animals in generating new clinical outbreaks, we 592 
believe further testing of candidates using a multi-antigen approach, possibly 593 
combined with an anti-tick component [53, 54], is warranted. Since a degree of 594 
conservation across vector borne Apicomplexa clearly exists for genes that promote 595 
transmission through the arthropod, it should be possible to consider development of 596 
generic strategies that are effective against this important group of pathogens. 597 
Progress towards this goal will depend on funded vaccine trials, these may be 598 
expedited by using smaller animal models to test candidates conserved across 599 
Piroplasmida.  600 
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Tables 
Table 1 
T. annulata 
ID 
Chr Product Annotation 
Signal 
peptide 
GPI 
anchor 
TMD 
Macro 
to mero 
FC 
Macro 
to piro 
FC 
Mero 
to piro 
FC 
T. parva ID dNdS 
Protein 
identity 
Nucleotide 
identity 
TA02580 3 Hypothetical protein -     0 2.14 2.74 1.28 TP03_0040 0.0732 28.07 46.00 
TA02585 3 Hypothetical protein -     0 1.32 2.34 1.77 TP03_0039 0.0127 31.29 47.24 
TA03640* 3 Hypothetical protein 
Sexual stage antigen 
(Pfam:PF07422) 
    0 3.55 4.14 1.17 TP03_0268 0.2529 64.17 73.18 
TA03755 3 
Sporozoite surface 
antigen (SPAG) 
P67 sporozoite 
(Pfam:PF05642) 
    1 4.23 4.29 1.01 TP03_0287 0.3260 49.85 63.60 
TA10955* 4 
Putative papain-family 
cysteine protease 
Cysteine-type peptidase 
activity (GO:0008234) 
    0 3.42 4.61 1.35 TP04_0598 0.0904 85.50 83.48 
TA13810 2 
Putative ts-chitose 
type 23 kDa piroplasm 
surface-like protein 
Orthologous to 
T. sergenti merozoite 
surface antigen 
    1 2.55 1.97 -1.29 TP02_0551 0.1638 83.41 84.57 
TA13825 2 Hypothetical protein -     1 12.40 11.00 -1.13 TP02_0553 0.4276 49.76 64.30 
TA16005 2 Hypothetical protein 
Domain of unknown 
function DUF529 
(Pfam:PF04385) 
    1 1.87 3.09 1.65 TP02_0950 0.3317 62.59 75.61 
TA16565 1 Hypothetical protein -     0 1.60 2.27 1.41 TP01_1144 0.2704 74.68 79.69 
TA17050* 1 
Merozoite-piroplasm 
surface antigen 
Tams1 
Merozoite antigen 
(Pfam:PF02488) 
    1 2.62 2.64 1.01 TP01_1056 0.2751 72.86 77.38 
TA17220 4 Hypothetical protein 
Domain of unknown 
function DUF529 
(Pfam:PF04385) 
    1 1.66 2.81 1.69 TP04_0030 0.3037 51.59 68.65 
TA20855* 1 Hypothetical protein 
Similarity to P. yoelii 
(SWALL:EAA20932) 
and P. falciparum 
(SWALL:Q8IE86) 
    0 2.57 2.63 1.03 TP01_0412 0.085 80.43 77.72 
 
Bioinformatic prediction of surface location of 12 candidates genes with significant fold change in gene expression levels between 
macroschizont and merozoite/piroplasm stages. Candidates selected for allelic sequencing are marked with an asterisk and protein and nucleotide 
identity are to the putative T. parva orthologue. 
Figure Legends 
Figure 1. Gene expression profile of 13 transmission-blocking candidates 
Microarray expression profiles (A), (B) and (C) of T. annulata candidate genes in sporozoite, schizont, 
merozoite Day 4, Day 7, Day 9 and piroplasm. Expression is depicted on a log2 scale.  
 
Figure 2. Protein alignments with related Apicomplexan genera 
A. Alignment of the conserved papain family cysteine protease domain of Serine Repeat Antigen (SERA)-
like Proteins from :  P. falciparum (PF3D7_0207600), P. reichenowi  (PRCDC_0206900), T. orientalis 
(TOT_040000333), T. annulata  (TA10995), T. parva (TP04_0598).     
                
B. Alignment of the highly conserved s48-45 superfamily 6-cysteine domain from sequences of TA03640 
homologues with conserved cysteine residues in green: P. vivax (PVP01_113600), P. yoellii  (PYO3100), P. 
chabaudi (PCHAS_0111600), T. annulata  (TA03640), T. parva (TP03_0268), T. orientalis  
(TOT_030000578),  B. bigemina (BBBOND_0402900).                      
 
C. Alignment of the highly conserved 8-cysteine domain region of (revised) TA20855 homologues with 
predicted signal peptides (blue), transmembrane helices (red) and cysteine residues (green) highlighted: V. 
brassicaformis (VBRA_17621), T. gondii  (TGME49_321580),  P. falciparum (PF3D7_1322900) T. 
annulata_revised   (TA20855),  B. bovis (BBOV_IV006060), B. bigemina (BBBOND_0208520). 
 
Figure 3. qRT-PCR of candidate genes in tick stages 
Quantitative RT-PCR expression analysis of RNA from T. annulata infected ticks generated at Day 2, Day 6, 
Day 10 and Day 15 post-detachment, relative to T. annulata merozoite Day 8 (calibrator) for: Tams1 
(TA17050); putative papain-family cysteine protease (TA10955); Pfs 48/45 6-cys domain encoding gene 
TA03640 and 6-Cys like gene TA20855. * above (positive) or below (negative) error bars denote degrees of 
significant difference (* p < 0.05, ** p < 0.01, *** p < 0.0001) between fold-change at a time-point relative 
to merozoite calibrator RNA. 
 
Figure 4. Diversifying selection and B cell epitopes in candidate genes 
 
dN/dS computed from allelic sequences of  (a) TA17050; (b) TA10955; (c) TA03460 and (d) TA20855, 
plotted against predicted B cell epitope regions (>1 amino acid, shaded areas) from GeneDB reference 
sequences for each protein. Epitopes with evidence of positive selection (peaks above 0) are shaded yellow, 
epitopes with no evidence of positive selection are shaded grey. ForTA20855 and TA10955, but not 
TA17050 or TA03640, there was a statistically significant association between predicted epitopes and 
positive dN/dS, reflected in the figure by more yellow shaded areas, relative to grey.  
 
  
Additional files 
 
Additional file 1 
Additional file 1.docx 
Revised gene models for T20855 and TA19820 validated by RNA-seq reads, and alternate prediction 
of TM helices of TA20855 using different software. 
 
Additional file 2 
Additional file 2.docx 
qRT-PCR and allelic sequencing primers 
 
Additional file 3 
Additional file 3.docx 
Transciptome data mined from EuPathDB for Plasmodium and Toxoplasma homologues of gene 
TA20855. 
 
 
Additional file 4 
Additional file 4.docx 
TA14250 encodes a second 6-cys (s48_45) domain protein, predicted to be expressed in the tick vector.  
 
Additional file 5 
Additional file 5.docx 
TA09115 encodes the HAP2 domain found in proteins essential for gamete fusion, predicted to be 
expressed in the tick vector.  
 
Additional file 6 
Additional file 6.docx 
TA19820 encodes a CPW-WPC domain protein, predicted to be expressed in the tick vector. 
 
 
 
